PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
6 hedge funds and large institutions have $784K invested in PAVmed Inc. Series Z Warrant in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.05M |
| 2 |
LCS
Levin Capital Strategies
New York
|
+$78.1K |
| 3 |
LWAC
Laurel Wealth Advisors (California)
Solana Beach,
California
|
+$22.2K |
| 4 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$11.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.86K |
Top Sellers
PAVMZ Hedge Fund Activity: Q2 2018 in Review
6 of the 4,385 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q2 2018, worth a combined $784K.
Buyers outnumbered sellers: 6 funds opened new PAVMZ positions and 0 closed out — a net gain of 6 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.05M.
- 6 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q2 2018, up from 0 in Q1 2018.
- Funds reported $784K of PAVmed Inc. Series Z Warrant stock for Q2 2018.
- 6 funds opened new PAVmed Inc. Series Z Warrant positions in Q2 2018 and 0 closed out, a net change of +6 holders.
- The largest PAVmed Inc. Series Z Warrant buyer in Q2 2018 was Sabby Management, an estimated $1.05M added.
Based on aggregated 13F filings for Q2 2018.